April 19, 2024
BOSTON — The US Food and Drug Administration (FDA) approved 55 new medications in 2023 and 11 more in 2024 to date. During a presentation on […]
April 19, 2024
TOPLINE: A study comparing the clinical reasoning of an artificial intelligence (AI) model with that of physicians found the AI outperformed residents and attending physicians in […]
April 17, 2024
Large-scale salt substitution holds promise for reducing mortality with no elevated risk of serious harms, especially for older people at increased cardiovascular disease (CVD) risk, a […]
April 17, 2024
Antibiotics had no measurable effect on the severity or duration of coughs due to acute lower respiratory tract infection (LRTI, or acute bronchitis), a large prospective […]
April 16, 2024
TOPLINE: Among people with type 2 diabetes (T2D) using insulin, sodium-glucose cotransporter 2 inhibitors (SGLT2is) were associated with a reduced risk for diabetic macular oedema (DMO) […]
April 1, 2024
LONDON (Reuters) – The mysterious “Havana syndrome” ailment that has afflicted U.S. diplomats and spies across the world may be linked to energy weapons wielded by […]
March 28, 2024
TOPLINE: A study involving over 260,000 patients found that neither text messages nor reminders in patient portals significantly increased rates of influenza vaccination. METHODOLOGY: The study […]
March 6, 2024
TOPLINE: Habitual short sleep duration was associated with an increased risk of developing type 2 diabetes (T2D), and this association persisted even among participants who maintained […]
March 1, 2024
“Fingers, toes, ears, and nose are places where epinephrine never goes,” wrote Thomas Ehlers, DPM, in Podiatry Today. “That is an adage I heard during podiatry […]